Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes

[1]  J. Passweg,et al.  Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. , 2017, Leukemia research.

[2]  Stephanie J. Lee,et al.  Late effects of blood and marrow transplantation , 2017, Haematologica.

[3]  Katsuhiro Shono,et al.  Autoimmune thyroid dysfunction after allogeneic hematopoietic stem cell transplant , 2016, Leukemia & lymphoma.

[4]  K. Kuntz,et al.  Prevalence of hematopoietic cell transplant survivors in the United States. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  M. Aljurf,et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation , 2012, Bone Marrow Transplantation.

[6]  R. Duarte,et al.  Thyroid dysfunction in adult patients late after autologous and allogeneic blood and marrow transplantation , 2012, Bone Marrow Transplantation.

[7]  M. Sorror,et al.  Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Storb,et al.  Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  D. Weisdorf,et al.  Similar risks for hypothyroidism after allogeneic hematopoietic cell transplantation using TBI-based myeloablative and reduced-intensity conditioning regimens , 2009, Bone Marrow Transplantation.

[10]  A. Barrett,et al.  Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  R. Storb,et al.  Thyroid function following hematopoietic cell transplantation in children: 30 years' experience. , 2009, Blood.

[12]  A. Nademanee,et al.  Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. , 2007, Blood.

[13]  E. Lanino,et al.  Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Cheetham,et al.  Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning , 2004, Bone Marrow Transplantation.

[15]  L. Pagano,et al.  High prevalence of endocrine dysfunction in long‐term survivors after allogeneic bone marrow transplantation for hematologic diseases , 2002, Cancer.

[16]  D. Spaner,et al.  Abnormal thyroid stimulating hormone (TSH) levels in adults following allogeneic bone marrow transplants , 1997, Bone Marrow Transplantation.

[17]  C. Sklar,et al.  Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. , 1995, Bone marrow transplantation.

[18]  C. Sklar,et al.  Thyroid dysfunction among long-term survivors of bone marrow transplantation. , 1982, The American journal of medicine.